364 related articles for article (PubMed ID: 23845456)
41. Prostate cancer: Escaping enzalutamide: Malat1 contributes to resistance.
Stone L
Nat Rev Urol; 2017 Aug; 14(8):450. PubMed ID: 28585559
[No Abstract] [Full Text] [Related]
42. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites.
West JA; Davis CP; Sunwoo H; Simon MD; Sadreyev RI; Wang PI; Tolstorukov MY; Kingston RE
Mol Cell; 2014 Sep; 55(5):791-802. PubMed ID: 25155612
[TBL] [Abstract][Full Text] [Related]
43. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer.
Shen L; Chen L; Wang Y; Jiang X; Xia H; Zhuang Z
J Neurooncol; 2015 Jan; 121(1):101-8. PubMed ID: 25217850
[TBL] [Abstract][Full Text] [Related]
44. Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9
Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C
Eur Urol; 2017 Nov; 72(5):835-844. PubMed ID: 28528814
[TBL] [Abstract][Full Text] [Related]
45. The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
Chakravarty D; Sboner A; Nair SS; Giannopoulou E; Li R; Hennig S; Mosquera JM; Pauwels J; Park K; Kossai M; MacDonald TY; Fontugne J; Erho N; Vergara IA; Ghadessi M; Davicioni E; Jenkins RB; Palanisamy N; Chen Z; Nakagawa S; Hirose T; Bander NH; Beltran H; Fox AH; Elemento O; Rubin MA
Nat Commun; 2014 Nov; 5():5383. PubMed ID: 25415230
[TBL] [Abstract][Full Text] [Related]
46. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
47. Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer.
Smolle MA; Bauernhofer T; Pummer K; Calin GA; Pichler M
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28241429
[TBL] [Abstract][Full Text] [Related]
48. The lncRNA PCAT29 inhibits oncogenic phenotypes in prostate cancer.
Malik R; Patel L; Prensner JR; Shi Y; Iyer MK; Subramaniyan S; Carley A; Niknafs YS; Sahu A; Han S; Ma T; Liu M; Asangani IA; Jing X; Cao X; Dhanasekaran SM; Robinson DR; Feng FY; Chinnaiyan AM
Mol Cancer Res; 2014 Aug; 12(8):1081-7. PubMed ID: 25030374
[TBL] [Abstract][Full Text] [Related]
49. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205.
Hirata H; Hinoda Y; Shahryari V; Deng G; Nakajima K; Tabatabai ZL; Ishii N; Dahiya R
Cancer Res; 2015 Apr; 75(7):1322-31. PubMed ID: 25600645
[TBL] [Abstract][Full Text] [Related]
50. PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer.
Prensner JR; Chen W; Iyer MK; Cao Q; Ma T; Han S; Sahu A; Malik R; Wilder-Romans K; Navone N; Logothetis CJ; Araujo JC; Pisters LL; Tewari AK; Canman CE; Knudsen KE; Kitabayashi N; Rubin MA; Demichelis F; Lawrence TS; Chinnaiyan AM; Feng FY
Cancer Res; 2014 Mar; 74(6):1651-60. PubMed ID: 24473064
[TBL] [Abstract][Full Text] [Related]
51. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
52. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/β-catenin signal pathway.
Ji Q; Liu X; Fu X; Zhang L; Sui H; Zhou L; Sun J; Cai J; Qin J; Ren J; Li Q
PLoS One; 2013; 8(11):e78700. PubMed ID: 24244343
[TBL] [Abstract][Full Text] [Related]
53. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells.
Wang X; Li M; Wang Z; Han S; Tang X; Ge Y; Zhou L; Zhou C; Yuan Q; Yang M
J Biol Chem; 2015 Feb; 290(7):3925-35. PubMed ID: 25538231
[TBL] [Abstract][Full Text] [Related]
54. A long noncoding RNA connects c-Myc to tumor metabolism.
Hung CL; Wang LY; Yu YL; Chen HW; Srivastava S; Petrovics G; Kung HJ
Proc Natl Acad Sci U S A; 2014 Dec; 111(52):18697-702. PubMed ID: 25512540
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of long non-coding RNA UCA1 predicts a poor prognosis in patients with esophageal squamous cell carcinoma.
Li JY; Ma X; Zhang CB
Int J Clin Exp Pathol; 2014; 7(11):7938-44. PubMed ID: 25550835
[TBL] [Abstract][Full Text] [Related]
56. Long noncoding RNAs: new players in prostate cancer.
Cheng W; Zhang Z; Wang J
Cancer Lett; 2013 Oct; 339(1):8-14. PubMed ID: 23856029
[TBL] [Abstract][Full Text] [Related]
57. Human MALAT-1 long non-coding RNA is overexpressed in cervical cancer metastasis and promotes cell proliferation, invasion and migration.
Zhang Y; Wang T; Huang HQ; Li W; Cheng XL; Yang J
J BUON; 2015; 20(6):1497-503. PubMed ID: 26854446
[TBL] [Abstract][Full Text] [Related]
58. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
59. Upregulation and clinicopathological significance of long non-coding NEAT1 RNA in NSCLC tissues.
Pan LJ; Zhong TF; Tang RX; Li P; Dang YW; Huang SN; Chen G
Asian Pac J Cancer Prev; 2015; 16(7):2851-5. PubMed ID: 25854373
[TBL] [Abstract][Full Text] [Related]
60. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling.
Wang Y; He L; Du Y; Zhu P; Huang G; Luo J; Yan X; Ye B; Li C; Xia P; Zhang G; Tian Y; Chen R; Fan Z
Cell Stem Cell; 2015 Apr; 16(4):413-25. PubMed ID: 25842979
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
